Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 11/20 | 0.71 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.71 |
| ▸ | MAPT | P10636 | 2/20 | 0.71 |
| ▸ | POLB | P06746 | 1/20 | 0.71 |
| ▸ | GAA | P10253 | 1/20 | 0.71 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.66 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.66 |
| ▸ | TSHR | P16473 | 1/20 | 0.66 |
| ▸ | PGR | P06401 | 3/20 | 0.65 |
| ▸ | SERPINA6 | P08185 | 2/20 | 0.65 |
| ▸ | LMNA | P02545 | 2/20 | 0.65 |
| ▸ | AR | P10275 | 2/20 | 0.65 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.65 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.64 |
| ▸ | NR3C1 | P04150 | 6/20 | 0.59 |
| ▸ | NR3C2 | P08235 | 3/20 | 0.59 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.59 |
| ▸ | SHBG | P04278 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13181574 | 0.97 | HIF1A (0.69) | HIF1ASMN1; SMN2MAPTPOLBGAA | |
| SCHEMBL13181585 | 0.94 | HIF1A (0.72) | HIF1ASMN1; SMN2MAPTPOLBGAA | |
| SCHEMBL13155898 | 0.90 | HIF1A (0.69) | HIF1ASMN1; SMN2MAPTPOLBGAA | |
| SCHEMBL13673705 | 0.89 | HIF1A (0.80) | HIF1ASMN1; SMN2MAPTPOLBGAA | |
| SCHEMBL13181578 | 0.88 | HIF1A (0.66) | HIF1ASMN1; SMN2MAPTPOLBGAA | |
| SCHEMBL14114120 | 0.88 | HIF1A (0.66) | HIF1ASMN1; SMN2MAPTPOLBGAA | |
| SCHEMBL13181661 | 0.88 | HIF1A (0.66) | HIF1ASMN1; SMN2MAPTPOLBGAA | |
| SCHEMBL13155894 | 0.87 | HIF1A (0.67) | HIF1ASMN1; SMN2MAPTPOLBGAA | |
| SCHEMBL12562630 | 0.87 | HIF1A (0.65) | HIF1ASMN1; SMN2MAPTPOLBGAA | |
| SCHEMBL13181583 | 0.85 | HIF1A (0.62) | HIF1ASMN1; SMN2MAPTPOLBGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100234334-A1 | NITRIC OXIDE RELEASING STEROIDS | NICOX S.A. (FR) | 2010-09-16 | — | — | US | disclosed |
| WO-2008095809-A1 | NITRIC OXIDE RELEASING STEROIDS | NICOX S.A. (FR) | 2008-08-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100234334-A1 | NITRIC OXIDE RELEASING STEROIDS | NOS1, NR3C1, NOS2 | HIF1A 887/4885SMN1; SMN2 3945/4885MAPT 4399/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.